(S)-10-Hydroxycamptothecin CAS 19685-09-7
€120 – €580
Synonyms: 10-HCPT, Hydroxycamptothecine
Download quality specification (S)-10-Hydroxycamptothecin-CAS-19685-09-7-QS.pdf
| 500 mg | € 120 |
| 1 g | € 170 |
| 2,5 g | € 320 |
| 5 g | € 580 |
| Cat. No. | NST-10-204 |
| CAS | 19685-09-7 |
| Purity | 98% (HPLC) |
| Appearance | Yellow Powder |
| Molecular formula | C20H16N2O5 |
| Molecular weight | 364,35 |
| Storage | store in a cool & dry place, keep away from strong light and heat |
Certificate of analysis available by request to [email protected]
(S)-10-Hydroxycamptothecin: Potent Topoisomerase I Inhibitor for Advanced Molecular Research
1. Molecular Identity
- Chemical Name: (S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- CAS Number: 19685-09-7
- Source: Semi-synthetic derivative of camptothecin, originally isolated from Camptotheca acuminata
2. Biochemical Significance
(S)-10-Hydroxycamptothecin is a potent topoisomerase I inhibitor with enhanced solubility compared to its parent compound, camptothecin. Its unique structure and mechanism of action make it a compound of significant interest in molecular and cellular research.
3. Key Properties
- Topoisomerase I Inhibition: Potent activity against DNA topoisomerase I
- Cellular Activity: Exhibits strong cytotoxicity against various cell lines
- Improved Solubility: Enhanced aqueous solubility compared to camptothecin
- S-Configuration: Demonstrates superior biological activity over the R-isomer
4. Potential Research Applications
- Small molecule optimization and screening platform development
- Structure-activity relationship studies of camptothecin analogues
- Investigation of topoisomerase I-mediated DNA interactions
- Development of targeted delivery systems for camptothecin derivatives
5. Current Research Focus
Ongoing studies are investigating (S)-10-Hydroxycamptothecin’s effects on:
- Various cell models, including resistant phenotypes
- Combination with other bioactive agents
- Nanoformulation strategies for enhanced delivery
- Mechanisms of response to topoisomerase I inhibition
6. Formulation Challenges and Innovations
Researchers are actively working on:
- Enhancing stability of the active lactone form
- Developing targeted delivery systems for improved performance
- Designing modified analogues for optimized release profiles
7. Regulatory Considerations
As a research compound, (S)-10-Hydroxycamptothecin (CAS 19685-09-7) is intended for use in controlled laboratory settings. Any application beyond fundamental research requires compliance with applicable regulations and safety standards.
8. Future Research Directions
The scientific community anticipates:
- Advanced in vitro and in vivo modeling for biological profiling
- Development of novel (S)-10-Hydroxycamptothecin analogues
- Exploration of potential applications beyond oncology models
9. Collaborative Opportunities
We invite molecular biologists, medicinal chemists, and academic institutions to explore the research potential of (S)-10-Hydroxycamptothecin. For inquiries, collaborations, or to discuss how this compound can support your scientific projects, please contact us at [email protected].
Join us in advancing cellular and molecular research with (S)-10-Hydroxycamptothecin – a key compound in the study of topoisomerase I inhibitors and their biological impact.
